Vidhi Shanghvi is the daughter of Dilip Shanghvi, India's richest healthcare billionare. She is Vice president and Head of ...

Sun Pharma Advanced Research Company (SPARC) signed a binding Letter of Intent (LoI) with the University of California, San Francisco (UCSF), and Tiller Therapeutics Inc. for a pre-clinical oncology ...

"This milestone marks a significant step forward for both organisations, allowing us to effectively leverage each other's strengths and capabilities," Sun Pharma Chairman and Managing Director ...

Sharing information with shareholders, Sun Pharmaceutical Industries Managing Director Dilip Shanghvi said the company's strategy of developing the specialty business as an additional growth ...

Talking about his vision for Sun Pharma, Shanghvi said, "Our focus has always been that each of our businesses should focus on improving its performance over what we did last year... We’ve been ...

India’s Sun Pharma has signed an agreement to take full control of Israeli generic drugmaker Taro Pharmaceutical Industries, taking it into private hands. New York Stock Exchange (NYSE)-listed ...

Sun Pharma will take up the amalgamation of five wholly-owned subsidiaries at an equity shareholder meet next month, the company said. The subsidiaries are being amalgamated as part of ongoing ...

India's Sun Pharmaceutical has signed an agreement to acquire US biotech Concert Pharmaceuticals and its lead drug deuroxilitinib, in phase 3 testing for alopecia areata, a leading cause of hair loss.